Effectiveness of tenapanor for treating hyperphosphatemia in patients receiving dialysis: a plain language summary of the OPTIMIZE study
Sign Up to like & getrecommendations! Published in 2024 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2024.2364815
Abstract: Plain Language Summary What is this summary about? This summary provides a review of the OPTIMIZE study, the results of which were published in Kidney360 in February 2024. The OPTIMIZE study looked at how well… read more here.
Keywords: plain language; optimize study; language; dialysis ... See more keywords
Safety of empagliflozin treatment in four clinical studies: a plain language summary
Sign Up to like & getrecommendations! Published in 2025 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2025.2547905
Abstract: Plain Language Summary What is this summary about? This meta-analysis looked at the safety of empagliflozin, by looking at the number of side effects in a broad range of participants who were taking empagliflozin for… read more here.
Keywords: number; participants took; plain language; language ... See more keywords
The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines
Sign Up to like & getrecommendations! Published in 2025 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2025.2536085
Abstract: Plain Language Summary What is this summary about? In 2012, the American Academy of Sleep Medicine (AASM) released a clinical practice guideline (CPG) to help clinicians treat patients suffering with restless legs syndrome (RLS) and… read more here.
Keywords: sleep medicine; plain language; academy; language ... See more keywords
Plain language summary: updated results of lorlatinib treatment in people with advanced NSCLC from China
Sign Up to like & getrecommendations! Published in 2024 at "Future Oncology"
DOI: 10.1080/14796694.2024.2426376
Abstract: Plain Language Summary What is this summary about? This study is about the effects of a medicine called lorlatinib (Lorbrena) in people from China with advanced ALK-positive non-small cell lung cancer (NSCLC) who had been… read more here.
Keywords: plain language; group; people group; language ... See more keywords
Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence?
Sign Up to like & getrecommendations! Published in 2024 at "Future Oncology"
DOI: 10.1080/14796694.2024.2426425
Abstract: Plain Language Summary What is this summary about? This is a plain language summary of two research articles originally published in the New England Journal of Medicine and NEJM Evidence. The EMBARK study included patients… read more here.
Keywords: cancer; plain language; high risk; language ... See more keywords
Asciminib versus bosutinib following 2 or more prior therapies in chronic myeloid leukemia: a plain language summary of the ASCEMBL study
Sign Up to like & getrecommendations! Published in 2025 at "Future Oncology"
DOI: 10.1080/14796694.2024.2439178
Abstract: Plain Language Summary What is this summary about? This is a summary of a publication about the ASCEMBL study, which was published in Blood in November of 2021. Overall, researchers wanted to learn how well… read more here.
Keywords: plain language; bosutinib; language; language summary ... See more keywords
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)
Sign Up to like & getrecommendations! Published in 2025 at "Future Oncology"
DOI: 10.1080/14796694.2024.2440277
Abstract: Plain Language Summary What is this summary about? ENZAMET is a large international clinical trial involving people with metastatic hormone sensitive prostate cancer (mHSPC). Prior to the trial, standard treatment included testosterone suppression and sometimes,… read more here.
Keywords: cancer; plain language; trial; language ... See more keywords
Plain language summary: how long do patients with metastatic castration-resistant prostate cancer (mCRPC) live when taking abiraterone or enzalutamide in the real world?
Sign Up to like & getrecommendations! Published in 2025 at "Future Oncology"
DOI: 10.1080/14796694.2025.2485752
Abstract: Plain Language Summary What is this summary about? This is a plain language summary of a research article published in Prostate Cancer and Prostatic Diseases Abiraterone and enzalutamide are medicines used to treat patients with… read more here.
Keywords: language summary; language; real world; plain language ... See more keywords
A plain language summary of the preliminary results for encorafenib plus binimetinib and pembrolizumab in adults with BRAF V600-mutant melanoma in the STARBOARD study
Sign Up to like & getrecommendations! Published in 2025 at "Future Oncology"
DOI: 10.1080/14796694.2025.2488226
Abstract: Plain Language Summary What is this summary about? This summary describes the initial phase of the STARBOARD study, known as a safety lead-in, which was conducted to compare the safety of two different encorafenib doses… read more here.
Keywords: plus binimetinib; plain language; binimetinib pembrolizumab; language ... See more keywords
Plain language summary of the THOR Cohort 1 study comparing treatment with erdafitinib or chemotherapy in advanced or metastatic urothelial cancer
Sign Up to like & getrecommendations! Published in 2025 at "Future Oncology"
DOI: 10.1080/14796694.2025.2511589
Abstract: Plain Language Summary What is this summary about? This is a plain language summary of an article published in The New England Journal of Medicine in 2023 describing results from Cohort 1 of the THOR… read more here.
Keywords: cancer; treatment; plain language; chemotherapy ... See more keywords
Pimitespib for advanced gastrointestinal stromal tumor: a plain language summary of the CHAPTER-GIST-301 study
Sign Up to like & getrecommendations! Published in 2025 at "Future Oncology"
DOI: 10.1080/14796694.2025.2525060
Abstract: Plain Language Summary What is this summary about? This is a summary describing the results from CHAPTER-GIST-301 a phase 3 clinical study evaluating a new drug therapy called pimitespib in people who have been diagnosed… read more here.
Keywords: plain language; gist 301; language; language summary ... See more keywords